反応式
[Cl:1][CH2:2][C:3]1[CH:28]=[CH:27][C:6]([C:7]([NH:9][C:10]2[S:11][C:12]3[C:18]([N:19]([CH2:21][CH2:22][O:23][CH3:24])[CH3:20])=[CH:17][CH:16]=[C:15]([O:25][CH3:26])[C:13]=3[N:14]=2)=[O:8])=[CH:5][CH:4]=1.[CH3:29][O:30][CH2:31][CH2:32][NH:33][CH3:34]>>[ClH:1].[ClH:1].[CH3:29][O:30][CH2:31][CH2:32][N:33]([CH2:2][C:3]1[CH:28]=[CH:27][C:6]([C:7]([NH:9][C:10]2[S:11][C:12]3[C:18]([N:19]([CH2:21][CH2:22][O:23][CH3:24])[CH3:20])=[CH:17][CH:16]=[C:15]([O:25][CH3:26])[C:13]=3[N:14]=2)=[O:8])=[CH:5][CH:4]=1)[CH3:34]参加物
反応物 2
生成物 1
実験手順
A mixture of 100 mg (0.24 mmol) 4-chloromethyl-N-{4-methoxy-7-[(2-methoxy-ethyl)-methyl-amino]-benzothiazol-2-yl}-benzamide and 212 mg (2.38 mmol) N-(2-methoxyethyl)methylamine was ultrasonicated at room temperature for 30 minutes. The reaction mixture was then concentrated it vactio and the residue purified by flash chromatography (ethyl acetate). The product-containing fractions were concentrated in vactio and the residue stirred with HCl in ether and ethyl acetate. The resulting crystals were collected by filtration and washed with ether to afford 110 mg (91%) 4-{[(2-methoxy-ethyl)-methyl-amino]-methyl}-N-{4-methoxy-7-[(2-methoxy-ethyl)-methyl-amino]-benzothiazol-2-yl}-benzamide dihydrochloride as a white crystalline solid. ES-MS m/e (%): 473 (M+H+, 100).
後処理
- customwas ultrasonicated at room temperature for 30 minutes
- concentrationThe reaction mixture was then concentrated it vactio
- customthe residue purified by flash chromatography (ethyl acetate)
- concentrationThe product-containing fractions were concentrated in vactio
- filtrationThe resulting crystals were collected by filtration
- washwashed with ether
出典と根拠
- ORDレコード
- ord-4b691e70949b484ca5d054d9b9c392dd
- 出典データセット
- uspto-grants-2004_03
- 特許番号
- US06713499B2
関連ノート
読み込み中…